ABCB4 and tyrosinemia: Cell therapy has been investigated in animal models with various extents of hepatocyte repopulation, including models of PFIC3 (Mdr2 knockout mice), PFIC2 (Abcb11 knockout mice) and hereditary tyrosinemia [118–120].